LEXX on the daily chart is on a big bullrun breaking out of an ascending broadening triangle
or megaphone pattern demostrative of increasing volatility. Retlative volumes are 2X the
historical comparison. Price is now on the approach to the highs of 2023 but is only 15% of
the all high highs of 19 at the neckline of a head and shoulders back in 2018-2019,...
The next challenge is to find the right exit point. Of course, this must be above the purchase and additional costs, i.e. possible commissions and spreads. To minimize the risk, it's better to get out sooner than too late. Here too, it is important to use technical analysis to identify the reversal points: At what point is there resistance from the bears? Where is...
$LLEX entry PT 6.30-7-8 Target PTs 15 and higher Long term PT 60
BULLISH CYPHER PATTERN
Spike in Volume
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in...
been watching this Cup and Handle form on the daily time frame and it has finally formed the handle and seems to have bounced, I'm looking for it to break its prior resistance of $6.84
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
Lexaria also announced the pricing of an underwritten public offering (the "Offering") of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of...
$13.2M mkt cap, 3.5M float. Freshly uplisted to NASDAQ. Closed $11M oversubscribed financing at $5.25 on January 14th and trading at discount at $4.40. Oversold on the daily (RSI @ 28). Accum/Dist is evening out after 3 days of selloff. Gap at 6.41. Cash + assets exceed current market cap.
